Home > Research > Publications & Outputs > Prospective donors’ perspectives on hematopoiet...

Research

Electronic data

  • RME-2022-0195_Proof_hi

    Accepted author manuscript, 802 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Prospective donors’ perspectives on hematopoietic cell donation for cell and gene therapy research and development

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Prospective donors’ perspectives on hematopoietic cell donation for cell and gene therapy research and development. / Hamad, Lina; Anthias, Chloe; O'Leary, Ann et al.
In: Regenerative Medicine, Vol. 18, No. 4, 30.04.2023, p. 301-311.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Hamad, L, Anthias, C, O'Leary, A, Gibson, D & Machin, L 2023, 'Prospective donors’ perspectives on hematopoietic cell donation for cell and gene therapy research and development', Regenerative Medicine, vol. 18, no. 4, pp. 301-311. https://doi.org/10.2217/rme-2022-0195

APA

Hamad, L., Anthias, C., O'Leary, A., Gibson, D., & Machin, L. (2023). Prospective donors’ perspectives on hematopoietic cell donation for cell and gene therapy research and development. Regenerative Medicine, 18(4), 301-311. https://doi.org/10.2217/rme-2022-0195

Vancouver

Hamad L, Anthias C, O'Leary A, Gibson D, Machin L. Prospective donors’ perspectives on hematopoietic cell donation for cell and gene therapy research and development. Regenerative Medicine. 2023 Apr 30;18(4):301-311. Epub 2023 Mar 9. doi: 10.2217/rme-2022-0195

Author

Hamad, Lina ; Anthias, Chloe ; O'Leary, Ann et al. / Prospective donors’ perspectives on hematopoietic cell donation for cell and gene therapy research and development. In: Regenerative Medicine. 2023 ; Vol. 18, No. 4. pp. 301-311.

Bibtex

@article{7845e6a5a3264babaf172bc8d68a2e16,
title = "Prospective donors{\textquoteright} perspectives on hematopoietic cell donation for cell and gene therapy research and development",
abstract = "Aims: To explore prospective donors{\textquoteright} attitudes and perceptions towards donating hematopoietic stem cells (HSCs) for novel treatments research and development (R&D). Methods: A survey was launched by Anthony Nolan (AN) to assess prospective donors{\textquoteright} willingness to donate HSCs for novel therapies R&D, and their degree of comfort with the AN collaborating with and receiving payment from external organizations. Results: Most participants (87%) were willing to donate for novel treatment R&D and were comfortable with AN collaborating with external organizations and receiving payment (91% and 80%, respectively). Conclusion: Results reveal an overall positive response towards donating HSCs for R&D. These findings can support stakeholders and policymakers in outlining donation practices that uphold donors{\textquoteright} safety and welfare. ",
author = "Lina Hamad and Chloe Anthias and Ann O'Leary and Daniel Gibson and Laura Machin",
year = "2023",
month = apr,
day = "30",
doi = "10.2217/rme-2022-0195",
language = "English",
volume = "18",
pages = "301--311",
journal = "Regenerative Medicine",
number = "4",

}

RIS

TY - JOUR

T1 - Prospective donors’ perspectives on hematopoietic cell donation for cell and gene therapy research and development

AU - Hamad, Lina

AU - Anthias, Chloe

AU - O'Leary, Ann

AU - Gibson, Daniel

AU - Machin, Laura

PY - 2023/4/30

Y1 - 2023/4/30

N2 - Aims: To explore prospective donors’ attitudes and perceptions towards donating hematopoietic stem cells (HSCs) for novel treatments research and development (R&D). Methods: A survey was launched by Anthony Nolan (AN) to assess prospective donors’ willingness to donate HSCs for novel therapies R&D, and their degree of comfort with the AN collaborating with and receiving payment from external organizations. Results: Most participants (87%) were willing to donate for novel treatment R&D and were comfortable with AN collaborating with external organizations and receiving payment (91% and 80%, respectively). Conclusion: Results reveal an overall positive response towards donating HSCs for R&D. These findings can support stakeholders and policymakers in outlining donation practices that uphold donors’ safety and welfare.

AB - Aims: To explore prospective donors’ attitudes and perceptions towards donating hematopoietic stem cells (HSCs) for novel treatments research and development (R&D). Methods: A survey was launched by Anthony Nolan (AN) to assess prospective donors’ willingness to donate HSCs for novel therapies R&D, and their degree of comfort with the AN collaborating with and receiving payment from external organizations. Results: Most participants (87%) were willing to donate for novel treatment R&D and were comfortable with AN collaborating with external organizations and receiving payment (91% and 80%, respectively). Conclusion: Results reveal an overall positive response towards donating HSCs for R&D. These findings can support stakeholders and policymakers in outlining donation practices that uphold donors’ safety and welfare.

U2 - 10.2217/rme-2022-0195

DO - 10.2217/rme-2022-0195

M3 - Journal article

VL - 18

SP - 301

EP - 311

JO - Regenerative Medicine

JF - Regenerative Medicine

IS - 4

ER -